Centre Hospitalier Intercommunal Creteil

chicreteil.fr

Total trials

127

Active

32

Phase 3

12

Total enrollment

77,514

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 7 of 7 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Aspirin 150 mg1
Dexmedetomidine Injectable Solution1
Glucose 5% Injectable Solution1
Azithromycin Oral1
Antibiotic monotherapy treatment and follow-up1
Antibiotic bitherapy treatment and follow-up1
REKOVELLE1

Next readouts

  • 2025-03-15
  • 2026-02
  • 2027-11-21
  • 2027-12-17
  • 2032-08-01

Top conditions

  • Covid194
  • Sickle Cell Disease4
  • Infertility4
  • Bronchopulmonary Dysplasia4
  • Endometriosis3
  • Pre-Eclampsia3
  • Chronic Obstructive Pulmonary Disease3
  • Macular Degeneration3

Frequently asked questions about Centre Hospitalier Intercommunal Creteil

How many clinical trials does Centre Hospitalier Intercommunal Creteil have on ClinicalTrials.gov?
Centre Hospitalier Intercommunal Creteil is listed as the lead sponsor on 127 clinical trials in ClinicalTrials.gov, 32 of which are currently active (recruiting, enrolling, or ongoing).
How many of Centre Hospitalier Intercommunal Creteil's trials are in Phase 3?
12 of Centre Hospitalier Intercommunal Creteil's trials are in Phase 3, spread across 7 active drug programs.
What therapeutic areas does Centre Hospitalier Intercommunal Creteil focus on?
Centre Hospitalier Intercommunal Creteil's most-studied conditions on ClinicalTrials.gov are Covid19, Sickle Cell Disease, Infertility, Bronchopulmonary Dysplasia, Endometriosis.
When are Centre Hospitalier Intercommunal Creteil's next clinical trial readouts?
Centre Hospitalier Intercommunal Creteil has 5 upcoming primary-completion readouts tracked here; the soonest is “Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis”, expected around 2025-03-15.